Literature DB >> 14501270

The descriptive epidemiology of second primary breast cancer.

Jonine L Bernstein1, Robert H Lapinski, Seema S Thakore, John T Doucette, W Douglas Thompson.   

Abstract

BACKGROUND: It is well established that the incidence rates of first primary breast cancer have been increasing over time. In contrast, the incidence rates of second primary breast cancer are largely undocumented. This study describes the epidemiology of second primary breast cancer among a population-based cohort of 305,533 U.S. women diagnosed with breast cancer between 1973 and 1998.
METHODS: We compared age-specific incidence rates for overall and second primary breast cancer according to year of diagnosis and demographic and tumor characteristics.
RESULTS: Overall, age-specific rates of breast cancer increased with increasing age and year of diagnosis, whereas incidence of second primary breast cancer peaked among young women and declined after 1988. Consistent with what is known about genetic susceptibility to breast cancer, at every age the rate of second primaries was greater than the overall rate; among women age 20 to 29 years the rate of second primary was more than 100 times greater. Although overall age-specific rates of breast cancer for African-American women were lower than for whites, rates of second primaries were higher. Women with a first primary that was either lobular or medullary had a greater likelihood of developing a second primary, although, there were relatively few with these histologic types.
CONCLUSIONS: The pattern of incidence rates for first and second primary breast cancer differ markedly over time and by age.

Entities:  

Mesh:

Year:  2003        PMID: 14501270     DOI: 10.1097/01.ede.0000072105.39021.6d

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  25 in total

1.  Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors.

Authors:  Rinaa S Punglia; Michael J Hassett
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

2.  Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.

Authors:  Chaya S Moskowitz; Joanne F Chou; Joseph P Neglia; Ann H Partridge; Rebecca M Howell; Lisa R Diller; Danielle Novetsky Friedman; Dana Barnea; Lindsay M Morton; Lucie M Turcotte; Michael A Arnold; Wendy M Leisenring; Gregory T Armstrong; Leslie L Robison; Kevin C Oeffinger; Tara O Henderson
Journal:  J Clin Oncol       Date:  2019-07-01       Impact factor: 44.544

3.  The impact of primary care physicians on follow-up care of underserved breast cancer survivors.

Authors:  Rose C Maly; Yihang Liu; Allison L Diamant; Amardeep Thind
Journal:  J Am Board Fam Med       Date:  2013 Nov-Dec       Impact factor: 2.657

4.  Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.

Authors:  Julia Prater; Fabio Valeri; Dimitri Korol; Sabine Rohrmann; Silvia Dehler
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-23       Impact factor: 4.553

5.  Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance.

Authors:  M H See; N Bhoo-Pathy; S Jamaris; A Kiran; D G Evans; C H Yip; N A Taib
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

6.  A descriptive study of second primary malignancies associated to breast cancer in a mexican Hispanic population.

Authors:  S Vidal-Millan; I Zeichner-Gancz; D Flores-Estrada; B E Vela-Rodríguez; M I Vazquez-López; C D Robles-Vidal; M T Ramirez-Ugalde; M Chávez-MacGregor
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

7.  Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.

Authors:  Chang Xia; Mary C Schroeder; Ronald J Weigel; Sonia L Sugg; Alexandra Thomas
Journal:  Ann Surg Oncol       Date:  2014-06-17       Impact factor: 5.344

8.  Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.

Authors:  Babette Siebold Saltzman; Kathleen E Malone; Jean A McDougall; Janet R Daling; Christopher I Li
Journal:  Breast Cancer Res Treat       Date:  2012-08-19       Impact factor: 4.872

9.  Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype.

Authors:  Elżbieta Senkus; Jolanta Szade; Beata Pieczyńska; Anna Zaczek; Joanna Pikiel; Katarzyna Sosińska-Mielcarek; Agnieszka Karpińska; Jacek Jassem
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

10.  Gastric metastasis of bilateral breast cancer.

Authors:  Omar Jmour; Asma Belaïd; Fahmi Mghirbi; Khalil Béhi; Raoudha Doghri; Farouk Benna
Journal:  J Gastrointest Oncol       Date:  2017-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.